Ashwini Kumar - Concepedia

Author

Ashwini Kumar

University of Helsinki ORCID

Also Known As

A KUMAR, A Kumar, A. Kumar, ASHWINI KUMAR, Ashwini Kumar, Komal K. Javarappa, Komal Kumar J, Komal Kumar Javarappa

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Institute for Molecular Medicine Finland Helsinki University Hospital Cornell University NewYork–Presbyterian Hospital

About

Ashwini Kumar is an author at University of Helsinki specializing in medicine, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	525
2	Immunology	4	4	382
3	Cell Biology	2	2	140
4	Biochemistry	1	1	27
5	Molecular Medicine	1	1	60

Ashwini Kumar

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Immunogenomic Landscape of Hematological Malignancies Olli Dufva, Petri Pölönen, Oscar Brück, Cancer Cell Hematological MalignancyCancer ImmunosurveillanceMedicineMalignant Blood DisorderHematology	2020	186
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia Disha Malani, Ashwini Kumar, Oscar Brück, Cancer Discovery	2021	182
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia Heikki Kuusanmäki, Aino‐Maija Leppä, Petri Pölönen, Haematologica	2019	176
Forced, not voluntary, exercise effectively induces neuroprotection in stroke Katherine Hayes, Shane Sprague, Miao Guo, Acta Neuropathologica	2008	146
Catecholamines increase monocyte TNF receptors and inhibit TNF through β<sub>2</sub>-adrenoreceptor activation Xavier Guirao, Ashwini Kumar, Joshua A. Katz, American Journal of Physiology-Endocrinology and Metabolism	1997	95
Nicotine exposure alters<i>in vivo</i>human responses to endotoxin Xavier Wittebole, Sae J. Hahm, S M Coyle, Clinical & Experimental Immunology ImmunologyInflammationMolecular PharmacologyNicotineInflammatory Marker	2006	86
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia Mika Kontro, Ashwini Kumar, Muntasir Mamun Majumder, Leukemia Hematological MalignancyHox Gene ExpressionMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood Disorder	2016	80
The etiology of pneumoperitoneum in the 21st century Ashwini Kumar, Mark T. Muir, Stephen M. Cohn, The Journal of Trauma: Injury, Infection, and Critical Care	2012	67
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia Shady Adnan Awad, Matti Kankainen, Teija Ojala, Blood Advances	2020	65
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia Jarno Kivioja, Angeliki Thanasopoulou, Ashwini Kumar, Leukemia Hematological MalignancyMedicineMalignant Blood DisorderImmunologyNavitoclax Act	2018	60

Page 1